HIGHLIGHTS
- who: Stefan Milutinovic and colleagues from the Systems Immunity University Research Institute, Henry Wellcome Building, School of Medicine, Cardiff University, Cardiff, United Kingdom, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland. , School of Biological Sciences, University of Auckland, Auckland, New Zealand. , Laboratory of Molecular Immunology, Sanford Burnham Prebys, La Jolla, California. , Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand. have published the research work: OPEN ACCESS, in the Journal: (JOURNAL) of 02/03/2023
- what: The authors show that a successful treatment response is dependent on coupling tumor-associated HEV (TA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.